Amphastar Pharmaceuticals, Inc. - stock earnings
AMPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 36.2 million USD | 178.1 million USD |
| 2023Q3 | 49.2 million USD | 180.6 million USD |
| 2023Q2 | 26.1 million USD | 145.7 million USD |
| 2023Q1 | 26.0 million USD | 140.0 million USD |
| 2022Q4 | 33.9 million USD | 135.0 million USD |
| 2022Q3 | 15.9 million USD | 120.1 million USD |
| 2022Q2 | 17.3 million USD | 123.5 million USD |
| 2022Q1 | 24.3 million USD | 120.4 million USD |
| 2021Q4 | 19.8 million USD | 120.9 million USD |
| 2021Q3 | 29.5 million USD | 112.2 million USD |
| 2021Q2 | 7.8 million USD | 101.7 million USD |
| 2021Q1 | 5.0 million USD | 103.0 million USD |
| 2020Q4 | -6.3 million USD | 95.9 million USD |
| 2020Q3 | 3.9 million USD | 83.4 million USD |
| 2020Q2 | -192000 USD | 85.8 million USD |
| 2020Q1 | 3.9 million USD | 84.7 million USD |
| 2019Q4 | -1.0 million USD | 83.4 million USD |
| 2019Q3 | 1.3 million USD | 80.1 million USD |
| 2019Q2 | 47.8 million USD | 79.0 million USD |
| 2019Q1 | 868000 USD | 79.8 million USD |
| 2018Q4 | 1.9 million USD | 89.7 million USD |
| 2018Q3 | 2.4 million USD | 75.5 million USD |
| 2018Q2 | -2.8 million USD | 71.0 million USD |
| 2018Q1 | -7.2 million USD | 58.4 million USD |
| 2017Q4 | 1.5 million USD | 60.4 million USD |
| 2017Q3 | 175000 USD | 57.9 million USD |
| 2017Q2 | 2.0 million USD | 65.2 million USD |
| 2017Q1 | 893000 USD | 56.7 million USD |
| 2016Q4 | -2.7 million USD | 63.5 million USD |
| 2016Q3 | 3.9 million USD | 64.2 million USD |
| 2016Q2 | 6.9 million USD | 68.0 million USD |
| 2016Q1 | 2.5 million USD | 59.4 million USD |
| 2015Q4 | 7.5 million USD | 76.9 million USD |
| 2015Q3 | -3.0 million USD | 63.9 million USD |
| 2015Q2 | -6.6 million USD | 53.9 million USD |
| 2015Q1 | -665000 USD | 56.9 million USD |
| 2014Q4 | -2.5 million USD | 55.9 million USD |
| 2014Q3 | -5.4 million USD | 59.7 million USD |
| 2014Q2 | -1.2 million USD | 49.0 million USD |
| 2014Q1 | -1.6 million USD | 45.9 million USD |
| 2013Q4 | 1.8 million USD | 54.9 million USD |
| 2013Q3 | -159000 USD | 59.3 million USD |
| 2013Q2 | 7.8 million USD | 62.5 million USD |
| 2013Q1 | 2.4 million USD | 53.0 million USD |
| 2012Q4 | 4.4 million USD | 52.1 million USD |
| 2012Q3 | 3.3 million USD | 56.6 million USD |
| 2012Q2 | 4.9 million USD | 49.4 million USD |
| 2012Q1 | 5.5 million USD | 46.2 million USD |
AMPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 137.5 million USD | 644.4 million USD |
| 2022 | 91.4 million USD | 499.0 million USD |
| 2021 | 62.1 million USD | 437.8 million USD |
| 2020 | 1.1 million USD | 349.8 million USD |
| 2019 | 48.9 million USD | 322.4 million USD |
| 2018 | -5.7 million USD | 294.7 million USD |
| 2017 | 4.5 million USD | 240.2 million USD |
| 2016 | 10.5 million USD | 255.2 million USD |
| 2015 | -2.8 million USD | 251.5 million USD |
| 2014 | -10.7 million USD | 210.5 million USD |
| 2013 | 11.9 million USD | 229.7 million USD |
| 2012 | 18.1 million USD | 204.3 million USD |
| 2011 | 7.8 million USD | 118.4 million USD |
AMPH
Price: $42.08
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.60 USD
P/E Ratio: 21.72
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 105125
Ebitda: 2.1 millionMarket Capitalization: 2.0 billion